Relmada Therapeutics Inc (RLMD) — Who Owns This Stock? 13F Breakdown (Q2 2026)

RLMD ranks #4020 out of 37501 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

RLMD is a top-conviction position for Squadron Capital Management LLC — at 15.8% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in RLMD belongs to Jupiter Topco LLC, but the position matters far more to Squadron Capital Management LLC, who has 15.8% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

BlackRock has added to its RLMD position for two straight quarters, increasing it by $45.3M to reach $51.4M today.

RLMD is up 1.8% today, and institutions have been net buyers of $144.8M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

RLMD reported a net loss of $61.9M over the trailing twelve months.

• Not yet profitable — net loss of $61.9M over the trailing twelve months
• Revenue declined 50.6% year over year
• Net income improved year over year, from -$67.8M to -$61.9M
• Operating cash flow was negative, using $45.8M in cash
• Current ratio of 14.62x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.09x equity — within a conventional range